Work

Supplemental Figure 1 from Mechanisms of Acquired Drug Resistance to the HDAC6 Selective Inhibitor Ricolinostat Reveals Rational Drug-Drug Combination with Ibrutinib

Year: 2023

Type: supplementary-materials

Abstract: Standard error values for ACY-1215 plus ibrutinib combinations in cell lines and primary human lymphoma samples. Viability was measured by CellTiter-Glo. Each experiment was performed in triplicate and repeated at least 2 times. The standard error was calculated for each (a) cell line and (b) primary human lymphoma sample for each time point and drug concentration. The tables represented here correspond to the experiments in Figure 4a and 4b.

DOI: 10.1158/1078-0432.22463784

Authors: Jennifer E. Amengual, Sathyen A. Prabhu, Maximilian Lombardo, Kelly Zullo, Paul M. Johannet, Yulissa Gonzalez, Luigi Scotto, Xavier Jirau Serrano, Ying Wei, Jimmy Duong, Renu Nandakumar, Serge Cremers, Akanksha Verma, Olivier Elemento, Owen A. O'Connor

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361885608

Cites:

Cited by:

Related to: 10